Amalio Telenti mainly focuses on Immunology, Genetics, Virology, Acquired immunodeficiency syndrome and Internal medicine. Amalio Telenti works in the field of Immunology, namely Viral load. In his study, which falls under the umbrella issue of Genetics, Antibacterial agent, Polymerase chain reaction and Gene is strongly linked to Mycobacterium tuberculosis.
His Virology study combines topics in areas such as T cell, NK-92, Interleukin 12, Antibody and Chemokine receptor. His work on Sida as part of his general Acquired immunodeficiency syndrome study is frequently connected to International community, thereby bridging the divide between different branches of science. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Surgery, Gastroenterology, Efavirenz and Ritonavir.
His main research concerns Genetics, Virology, Immunology, Gene and Genome. His studies in Virology integrate themes in fields like Antibody, Monoclonal antibody and Antigen. His Immunology study combines topics from a wide range of disciplines, such as Internal medicine and Acquired immunodeficiency syndrome.
While the research belongs to areas of Internal medicine, Amalio Telenti spends his time largely on the problem of Efavirenz, intersecting his research to questions surrounding Reverse-transcriptase inhibitor, Lopinavir, Ritonavir, Nelfinavir and Indinavir. As part of his studies on Gene, Amalio Telenti often connects relevant subjects like Microbiology. His Genome research integrates issues from Exome sequencing and Computational biology.
His primary scientific interests are in Genetics, Genome, Computational biology, Gene and Genomics. His study on Whole genome sequencing, Genome-wide association study, Retinitis pigmentosa and Allele frequency is often connected to Identification as part of broader study in Genetics. His Gene course of study focuses on Microbiology and Flora, Urine, 16S ribosomal RNA and Metagenomics.
His study explores the link between Transcriptome and topics such as Single cell sequencing that cross with problems in Virology. His work deals with themes such as Immunology and Intensive care medicine, which intersect with Disease. Amalio Telenti is involved in the study of Immunology that focuses on Immune system in particular.
His scientific interests lie mostly in Virology, Gene, Genetics, Human genome and Genome. Amalio Telenti combines subjects such as Antibody and GTPase with his study of Virology. His research in Gene intersects with topics in Infectivity, Interferon, Guanosine and Effector.
His Genetics research is multidisciplinary, relying on both Disease and Metabolomics. The concepts of his Genome study are interwoven with issues in Contrast, Computational biology and Allele frequency. His Carcinogenesis study integrates concerns from other disciplines, such as Immunology and Metagenomics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel
Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
A Telenti;P Imboden;F Marchesi;L Matter.
The Lancet (1993)
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.
A Telenti;F Marchesi;M Balz;F Bally.
Journal of Clinical Microbiology (1993)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai.
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo.
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob.
The Lancet (2000)
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study
Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti.
The Lancet (1999)
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.
Catia Marzolini;Amalio Telenti;Laurent A. Decosterd;Gilbert Greub.
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
Dora Pinto;Young Jun Park;Martina Beltramello;Alexandra C. Walls.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: